Make Better Decisions

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Federal Trade Commission
Daiichi Sankyo
Express Scripts
Queensland Health

Generated: February 17, 2018

DrugPatentWatch Database Preview

Drugs in MeSH Category Angiotensin-Converting Enzyme Inhibitors

« Back to Dashboard

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
MylanENALAPRIL MALEATEenalapril maleateTABLET;ORAL075480-002Aug 22, 2000ABRXNoNo➤ Sign Up➤ Sign Up➤ Sign Up
SandozLISINOPRILlisinoprilTABLET;ORAL075999-005Jul 1, 2002DISCNNoNo➤ Sign Up➤ Sign Up➤ Sign Up
Zydus Pharms Usa IncRAMIPRILramiprilTABLET;ORAL090697-001Sep 24, 2009DISCNNoNo➤ Sign Up➤ Sign Up➤ Sign Up
Watson LabsENALAPRIL MALEATEenalapril maleateTABLET;ORAL075501-004Aug 22, 2000DISCNNoNo➤ Sign Up➤ Sign Up➤ Sign Up
CiplaRAMIPRILramiprilCAPSULE;ORAL077004-002Aug 7, 2008DISCNNoNo➤ Sign Up➤ Sign Up➤ Sign Up
Accord HlthcareLISINOPRILlisinoprilTABLET;ORAL202554-003Jul 30, 2013ABRXNoNo➤ Sign Up➤ Sign Up➤ Sign Up
Watson LabsCAPTOPRILcaptoprilTABLET;ORAL074451-003Feb 13, 1996DISCNNoNo➤ Sign Up➤ Sign Up➤ Sign Up
Aurobindo Pharma LtdFOSINOPRIL SODIUMfosinopril sodiumTABLET;ORAL091163-003Mar 30, 2011ABRXNoNo➤ Sign Up➤ Sign Up➤ Sign Up
MylanENALAPRIL MALEATEenalapril maleateTABLET;ORAL075472-001Aug 22, 2000DISCNNoNo➤ Sign Up➤ Sign Up➤ Sign Up
Invagen PharmsLISINOPRILlisinoprilTABLET;ORAL203508-002Oct 29, 2013ABRXNoNo➤ Sign Up➤ Sign Up➤ Sign Up
This preview shows a limited number of results
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Argus Health
Daiichi Sankyo
Cantor Fitzgerald

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2018 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch: